These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 6538196

  • 1. Kinetics of the activation of plasminogen by natural and recombinant tissue-type plasminogen activator.
    Zamarron C, Lijnen HR, Collen D.
    J Biol Chem; 1984 Feb 25; 259(4):2080-3. PubMed ID: 6538196
    [Abstract] [Full Text] [Related]

  • 2. Kinetic studies of plasminogen activation by epithelial tissue plasminogen activator.
    Electricwala A, Ling RJ, Atkinson T.
    Blood Coagul Fibrinolysis; 1990 Feb 25; 1(1):31-9. PubMed ID: 2129390
    [Abstract] [Full Text] [Related]

  • 3. The interaction of streptokinase.plasminogen activator complex, tissue-type plasminogen activator, urokinase and their acylated derivatives with fibrin and cyanogen bromide digest of fibrinogen. Relationship to fibrinolytic potency in vitro.
    Cassels R, Fears R, Smith RA.
    Biochem J; 1987 Oct 15; 247(2):395-400. PubMed ID: 3122725
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Identification of a site in fibrin(ogen) which is involved in the acceleration of plasminogen activation by tissue-type plasminogen activator.
    Nieuwenhuizen W, Vermond A, Voskuilen M, Traas DW, Verheijen JH.
    Biochim Biophys Acta; 1983 Oct 17; 748(1):86-92. PubMed ID: 6684481
    [Abstract] [Full Text] [Related]

  • 7. Studies on the kinetics of plasminogen activation by tissue plasminogen activator.
    Rånby M.
    Biochim Biophys Acta; 1982 Jun 24; 704(3):461-9. PubMed ID: 6214279
    [Abstract] [Full Text] [Related]

  • 8. Functional characterization of monoclonal antibodies directed against fibrin binding domains of tissue-type plasminogen activator.
    Wojta J, Beckmann R, Turcu L, Wagner OF, van Zonneveld AJ, Binder BR.
    J Biol Chem; 1989 May 15; 264(14):7957-61. PubMed ID: 2470738
    [Abstract] [Full Text] [Related]

  • 9. Species specificity in the acceleration of tissue-type plasminogen activator-mediated activation of plasminogens, by fibrinogen cyanogen bromide fragments.
    Nieuwenhuizen W, Keyser J.
    Thromb Res; 1985 Jun 15; 38(6):663-70. PubMed ID: 4040660
    [Abstract] [Full Text] [Related]

  • 10. Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin.
    Hoylaerts M, Rijken DC, Lijnen HR, Collen D.
    J Biol Chem; 1982 Mar 25; 257(6):2912-9. PubMed ID: 7199524
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A monoclonal antibody preventing binding of tissue-type plasminogen activator to fibrin: useful to monitor fibrinogen breakdown during t-PA infusion.
    Holvoet P, Lijnen HR, Collen D.
    Blood; 1986 May 25; 67(5):1482-7. PubMed ID: 3083892
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Characterization of the interactions of plasminogen and tissue and vampire bat plasminogen activators with fibrinogen, fibrin, and the complex of D-dimer noncovalently linked to fragment E.
    Stewart RJ, Fredenburgh JC, Weitz JI.
    J Biol Chem; 1998 Jul 17; 273(29):18292-9. PubMed ID: 9660794
    [Abstract] [Full Text] [Related]

  • 15. Differences in effects of fibrin(ogen) fragments on the activation of 1-glu-plasminogen and 442-val-plasminogen by tissue-type plasminogen activator.
    Verheijen JH, Nieuwenhuizen W, Traas DW, Chang GT, Hoegee E.
    Thromb Res; 1983 Oct 01; 32(1):87-92. PubMed ID: 6229056
    [Abstract] [Full Text] [Related]

  • 16. The effects of fibrinogen and its cleavage products on the kinetics of plasminogen activation by urokinase and subsequent plasmin activity.
    Lucas MA, Straight DL, Fretto LJ, McKee PA.
    J Biol Chem; 1983 Oct 25; 258(20):12171-7. PubMed ID: 6226655
    [Abstract] [Full Text] [Related]

  • 17. Characterization of a chimeric plasminogen activator consisting of amino acids 1 to 274 of tissue-type plasminogen activator and amino acids 138 to 411 of single-chain urokinase-type plasminogen activator.
    Lijnen HR, Nelles L, Van Hoef B, Demarsin E, Collen D.
    J Biol Chem; 1988 Dec 15; 263(35):19083-91. PubMed ID: 3143723
    [Abstract] [Full Text] [Related]

  • 18. On the molecular interactions between fibrin, tissue-type plasminogen activator and plasminogen.
    Lijnen HR, Van Hoef B, Collen D.
    Thromb Res Suppl; 1990 Dec 15; 10():45-54. PubMed ID: 2107598
    [Abstract] [Full Text] [Related]

  • 19. Importance of the interaction between plasminogen and fibrin for plasminogen activation by tissue-type plasminogen activator.
    Dunn FW, Deguchi K, Soria J, Soria C, Lijnen HR, Tobelem G, Caen J.
    Thromb Res; 1984 Nov 15; 36(4):345-51. PubMed ID: 6543039
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the effects of fibrinogen and fibrin products and isolated peptide chains on the fibrin-mediated stimulation of plasminogen activation by tissue-type plasminogen activator, and on the fibrin-dependent enhancement of the amidolytic activity of one-chain tissue-type plasminogen activator.
    Fischer B.
    Biol Chem Hoppe Seyler; 1990 Nov 15; 371(11):1067-75. PubMed ID: 2128181
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.